chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receipt of the vaccine, I developed a low grade fever the next day (1/7/21) that persisted throughout the day until it progressed into a fever of at least 101.3 F at night. It might have been higher, but that was the best reading I could get. It felt like the fever came on extremely fast bc all of a sudden I started shaking vigorously with rigors and chills. I couldn't get out of bed without experiencing the most uncomfortable chills I've ever experienced. I previously had Covid in early November, and this fever felt worse than what I experienced when I actually had Covid. Also, I experienced moderate to severe pain in my left arm on 1/7/21 at the injection site, which was far worse than any other muscle soreness I've experienced from any other vaccine I've received. The hour preceding the sudden fever attack, my left arm was feeling blazing hot, looked a little red, and swollen. I also experienced a strange allodynia type pain, whereby parts of my body hurt from simply touching them. Although I did not develop a significant rash, I experienced pruritus all over my body, predominantly affecting the areas around my ankles and wrists. I have a hx of multiple dermal filler injections in my lips. I don't think I had any problems with my lips after the injection. But other symptoms that I developed included a tickle in my throat and some shortness of air. On 1/8/21, I woke up drenched in sweat so I presumed that I broke my fever while sleeping. I have felt much better ever since. I'm a nurse practitioner student, and I had to miss a day of clinical on 1/8/21 bc of this reaction to the vaccine. I used ibuprofen the morning on 1/7/21 and Tylenol at night on 1/7/21 to bring down my fever
Swollen supraclavicular lymph nodes (2 bumps) 12/28/2020  7:00 pm  1 week after. None other side effects
Heart attack; This is a spontaneous report received from a contactable consumer or other non-health care professional via Medical Information Team. This consumer reported for a patient (cousin).   A patient of unspecified age and gender received bnt162b2 (COVID-19 VACCINE  MANUFACTURER UNKNOWN, Formulation: Solution for injection, Batch/Lot Number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced heart attack on an unspecified date. The event assessed as serious (hospitalization, medically significant). Caller stated she was concerned about various information she was finding around the FDA approval of the Comirnaty Vaccine. Caller stated her employer was planning on mandating vaccination against Covid-19, but she was concerned because she had two cousins that had heart attacks and another who had a severe allergic reaction with paralysis from the neck down to an unspecified Covid-19 Vaccine. They were hospitalized. The outcome of the event was reported as unknown.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
pain at the left arm injection site.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the left arm injection site.) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043120A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain at the left arm injection site.). At the time of the report, VACCINATION SITE PAIN (pain at the left arm injection site.) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication was reported by the reporter.  No treatment medication was reported by the reporter.   This case was linked to MOD-2022-455784 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2022: Follow up received contain no significant information.
On 12/28/20 at approximately 1700 hours I felt slightly drowsy and warm. I checked my temperature with a tympanic thermometer which read 98.4. At around 1900 hours I began to feel I had a fever and chills. Temperature was checked again and it read 101.2. I went to bed around 2200 hours where I continued to experience moderate fever and chills. At around 0100 hours on 12/29/20 I had profuse sweating, headache. I took tylenol PM and awoke at around 0730 hours on 12/29/20 and found I no longer had any symptoms.
Fever and pale, shallow breathing 30-60 minutes. Hx neonatal seizure. Parent took child to ER in Vermont, saw MD porb atypical seizure.
This spontaneous report received from a patient concerned a 30 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included Depo-Provera allergy, alcohol user, and non-smoker, and other pre-existing medical conditions included patient did not have had any medical history.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced the whole left side arm and leg got numb. On 07-APR-2021, the subject experienced the whole left side arm and leg got tingly. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from the whole left side arm and leg got numb, and the whole left side arm and leg got tingly. This report was non-serious.
Diarrhea 4 days after Rotateq (6/26/09). Change in formula before vaccine to Prosobee. Seen for gastritis 6/30/09-diarrea x 3d.
1 week after vaccine, patient developed a diffuse morbilliform eruption associated with itch and rash
Pt was given PENTACEL instead of QUADRACEL. I spoke with staff at the health department and she states that pt isn't going to be harmed by this- just an extra dose of HIB and that this will count on registry.
Chills; Fever; Very itchy rash on right fore arm/ Allergic contact dermatitis/ Rash from elbow down arm which looks like poison ivy/ Itching like crazy; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS CONTACT (Very itchy rash on right fore arm/ Allergic contact dermatitis/ Rash from elbow down arm which looks like poison ivy/ Itching like crazy), CHILLS (Chills) and PYREXIA (Fever) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 010M20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included SIMVASTATIN and ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION) for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DERMATITIS CONTACT (Very itchy rash on right fore arm/ Allergic contact dermatitis/ Rash from elbow down arm which looks like poison ivy/ Itching like crazy). On an unknown date, the patient experienced CHILLS (Chills) and PYREXIA (Fever). The patient was treated with TRIAMCINOLONE ACETONIDE (TRIAMCINOLON [TRIAMCINOLONE ACETONIDE]) on 05-Apr-2021 for Allergic contact dermatitis, at a dose of 1 dosage form once a day and CETIRIZINE HCL for Adverse event, at a dose of 10 milligram. At the time of the report, DERMATITIS CONTACT (Very itchy rash on right fore arm/ Allergic contact dermatitis/ Rash from elbow down arm which looks like poison ivy/ Itching like crazy) was resolving and CHILLS (Chills) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Laboratory test: negative (Negative) Possible shingles was tested negative.         On 25-Mar-2021, after second vaccination, the patient noticed a very itchy rash on right forearm. Initially the patient thought of it as poison ivy. It started to spread to more of forearm.  On 05-Apr-2021, the patient visited a dermatologist and the rash was diagnosed as allergic contact dermatitis. The patient was prescribed with triamcinolone acetonide to be used daily.  On 19-Apr-2021, during follow-up exam, the rash had mostly gone away.   Most recent FOLLOW-UP information incorporated above includes: On 27-Sep-2021: Follow-up received: lab data, concomitant, treatment medication and event verbatim and coding of rash were updated.
2 pm (1 hr after vaccination...felt strange feeling in the brain ... my son did, too on his shot.) 8 pm  Shook so much and teeth chattered; didn't want my teeth to chip. Jumped in a hot shower for 15 minutes and that went away.  I thought maybe my blood pressure had dropped too low; had same reaction when first put on too much blood pressure lowering medication.  Or sometimes allergy makes the blood pressure drop. For 24 hours after that I was on the couch or in bed lying down;  brain hurt(BAD headache), stiff neck, a big effort to lift my head off the pillow so I didn't unless I had to go to the bathroom.  I laid back down asap due to slight nausea.  No appetite. Whites of eyes were uniformly pink, eyes glassy.  3/23  Sore spot  to the touch on left temple just above the eyebrow.
Achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN (Achy). At the time of the report, PAIN (Achy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 13-Jun-2021: Follow-up received on 13-jun-2021 and does not have any new information
Lethargy, flank pain, infrequent fevers, change in sleep pattern, diminished appetite, increased sensitivity to caffeine. Unknown if related to vaccination, severe side pain and hypotensive episode prompted a urgent care visit,
pt recv vax 6AUG98 & w/in 2min passed out, seated in a chart, & exhibited a tonic stiffening like a sz but over w/in 20 seconds;afterward, pulse rate 57, Bp 100/60;d/t dizziness & allerg rxn;dx vasovagal syncope/sz;
I went to rest room an on my way back to my bed, I fell back on my bed feeling faint.  I called 911 and was told that my Hbg 7.9 I was transfused once while there and then discharged.  It again happened again 3 weeks later so I went back and was transfused again from 4/29 - 5/4/21. I was also told that I had tested positive for cover and my Hgb had dropped to 6.2 but could not find where the bleeding was.  I came to receive my next dose but the staff informed me that d/t Covid Pos and previous illness that I would not be vaccinated today and to come back in 2-3 months.
Patient had lap chole 6 weeks after second Moderna shot and developed multisegmental PE 2 days afterwards.  No known clotting issues.
Ten days after injection, I experienced sudden onset of headache, upper back pain, fatigue and ? the most concerning and unanticipated? swelling, tenderness, and rash involving most of my left breast.  The headache, fatigue, and pain resolved within one day.  The breast symptoms gradually resolved over four days.
BAD REACTION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: unknown) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. Batch no.is not reported and it is requested. No concomitant medications were reported.  On an unspecified date, the subject experienced bad reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of bad reaction was not reported. This report was non-serious.
Information has been received from the mother of a female consumer who in January 2007, was vaccinated with a dose of Gardasil. The patient experienced pain, a rash and then full blown blisters. She went to her physician and was diagnosed as shingles. The patient's outcome was unknown. No further information is available.
An 11 year old male patient experienced fever, headache, vomiting, hives and asthma symptoms after post exposure vaccination with RabAvert. The patient received his third does of RabAvert, 1 ml intramuscularly into the deltoid on 09/15/04. His post medical history was significant for asthma. His concomitant medications included Flovent and Albuterol. The patient tolerated his first and second doses of RabAvert without incident. On 09/16/04, on day after his third dose of RabAvert, the patient developed a fever of 102.5 degrees, headache and vomiting that resolved after two to three days. In addition, approximately 72 hours after the third dose, he also developed asthma symptoms (chest tightness) and hives. The asthma symptoms resolved with treatment of Flovent and Albuterol. The hives were limited to his arms and resolved without treatment. Prior to the occurrence of the asthma symptoms and hives, the patient was reportedly playing outside. Additional information received on 09/23/04: The patient received RabAvert due to exposure to a rabies positive bat at home. Prior to his third dose of RabAvert, the patient complained of fatigue, achiness and an upset stomach. His physician asserted that it was unclear whether the patient had a hypersensitivity reaction to RabAvert, or that he had a viral syndrome concomitant with the third RabAvert vaccination and later (72 hours) he exhibited asthmatic symptoms as he had done on previous occasions.
This spontaneous report was received from a nurse practitioner and refers to a 25-year-old female patient. The patient's medical history were not reported. The patient's concurrent conditions included multiple psychiatric disorders and concomitant medications included multiple psychiatric medications. On an unknown date (also reported as "when the patient was 11 years old"), the patient was vaccinated with the first and only dose of GARDASIL injection (route of administration, lot# and expiration date were not reported) for immunisation. On an unknown date (also reported as "a couple weeks after receiving GARDASIL"), the patient experienced a systemic autoimmune response. No laboratory tests were performed. The outcome of the event was unknown. The relatedness between the events and GARDASIL was not reported. Upon internal review, the event of systemic immune activation was considered to be medically significant.
dx = myocarditis Briefly, pt is an active male who is currently playing football and began complaining of chest pain around 1 prior to admission ago, shortly after COVID-19 vaccine on 8/31. Several episodes of vomiting and diarrhea the last 3 days. Initially grandmother (guardian) thought chest pain was related to football injury; however, following increased complaints of chest pain, accompanied by shortness of breath and fatigue, pt was taken to the ED at hospital. Troponin in the ED was 16 and ST segment elevation consistent with myocarditis.   Pt was admitted to the floor. Follow-up troponin this afternoon was increased to 63. Additionally, telemetry while on the floor was reviewed and 2 6-beat runs of ventricular tachycardia were noted. For these reasons, the patient was transferred to the CICU for further monitoring and management. Viral panel resulted as rhinovirus positive, but asymptomatic.  He was in the cardiac ICU for 3 days. Had 2 runs of VT treated with metoprolol. Received IVIG and was placed on NC to maintain saturations above 90%.   He was febrile after transfer to the floor but cultures were negative. Troponins downtrended. CRP initially uptrended. Cardiac MRI showed fibrosis. Cardiology determined they were less confident in COVID vaccine as the cause for his myocarditis given this, fever, and uptrending CRP. Rheumatology and ID were consulted, work up for MISC was negative (had covid in Feb). Troponin, BNP, CRP all continued to downtrend until he was deemed safe for discharge on 9/17. Enalapril and spirinolactone were started without complications and given resolving AKI. A TTE was obtained day prior to discharge, and was read as normal.
Information has been received from a pharmacist concerning a female who was vaccinated on an unspecified date with Zostavax.  On an unknown date, the patient developed shingles post vaccination.  It was reported that "it was not that bad of a case".  Unspecified medical attention was sought.  The outcome is reported as unknown.  No product quality complaint was involved.  Additional information has been requested.
This case was reported by a physician via call center representative and described the occurrence of hearing loss in a 73-year-old male patient who received RABAVERT. On 27th April 2016, the patient received the 3rd dose of RABAVERT. On 30th April 2016, 3 days after receiving RABAVERT, the patient experienced labyrinthitis. On 1st May 2016, the patient experienced hearing loss (serious criteria GSK medically significant) and ear buzzing. On an unknown date, the outcome of the hearing loss, labyrinthitis and ear buzzing were recovering/resolving. The reporter considered the hearing loss, labyrinthitis and ear buzzing to be possibly related to RABAVERT. Additional details were provided as follows: The patient who was a physician, reported that after 3rd dose of RABAVERT, he experienced acute labyrinthitis. The issue was bad, but it was improving. On 1st May 2016, 4 days after vaccination, the patient also noted that he was experiencing buzzing and had hearing loss. The patient was asking about the use of steroids for this with the product. The patient was transferred to Medical Information.
Covid Pfizer 5-11yr vaccine given instead of the Covid Pfizer 12yr + vaccine.
Large red area, warm to touch, no pain, within 24 hours (R) delt.
Received Td booster on 2-23-04 in left deltoid.  Came to Employee Health office with c/o sore, red arm on 2-25-04.  Red area noted approx 1" x 4", warm to touch, slight swelling.  Denied itching or difficulty breathing.  Encouraged to use cold compresses and Benadryl and to return if worse.  Returned to office on 2-27-04 with c/o red, sore, itchy arm.  Sent to ED for evaluation.  Given Atarax and Prednisone in ED and script for Medrol dose pak and Atarax for home.  Symptoms were relieved.  No further difficulty.
Pt. received vaccine on 1/15/17 at 3 pm. Pt. called 1/16/17 at 12 pm stating swollen glands - pt was advised to take BENADRYL. Around 1 pm, pt. was contacted stated going to urgent care. Tried following up with patient the next day, no response.
ER visit because of the throat swelling; Along with tongue swelling; Making breathing difficult; Redness in the arm / looked like an infection / Another visit to the ER; Arm / swelling- "blew up like a balloon / Swelling and redness in the shot area; Reaction continued with a redness in the arm / looked like an infection / redness in the shot area; There were body aches; Took off work days / loss of work time; This case was reported by a consumer via call center representative and described the occurrence of injection site infection in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th May 2021, the patient received the 1st dose of Shingrix. On 18th May 2021, less than a day after receiving Shingrix, the patient experienced injection site infection, injection site swelling, injection site erythema, general body pain and activities of daily living impaired. On 19th May 2021, the patient experienced throat swelling, swollen tongue and difficulty breathing. The patient was treated with benadryl (nos) (Benadryl) and antibiotics nos (Antibiotic (Details Unknown)). On an unknown date, the outcome of the injection site infection, injection site swelling, injection site erythema, general body pain, activities of daily living impaired, throat swelling, swollen tongue and difficulty breathing were not recovered/not resolved.   It was unknown if the reporter considered the injection site infection, injection site swelling, injection site erythema, general body pain, activities of daily living impaired, throat swelling, swollen tongue and difficulty breathing to be related to Shingrix.  Additional details were provided as follows:  The patient had reported the case for herself. The patient received vaccine on Tuesday in the doctor's office and experienced the reaction of the shot in the arm as a swelling, which was blew up like a balloon. There were body aches and the patient took off work days. On Wednesday night, 19th May 2021, there was an ER (emergency room) visit because of the throat swelling making breathing difficult along with tongue swelling and there was no hospital admission on this date. The patient was assigned an OTC (over the counter), Benedryl, over the weekend, the patient reported that the arm did not get better. The reaction continued with a redness in the arm and it was looked like an infection. The patient had another visit to the emergency room on Saturday night, 22nd May 2021, and she was not admitted to the hospital. The patient was administered an antibiotic. The patient was upset and wanted the company to know about these details, she expressed concern over the costs of emergency room visits, loss of work time, and cost of co-pays paid. The patient expressed a desire to possible have reimbursements. The reporter consented to follow-up.
Hives (diffuse urticarial rash) started mid-morning day after vaccine - no wheezing or respiratory compromise reported. Child is warm to touch but temperature not taken
During the shipping of vaccine to immunization clinic on 20JUL2010 temperature was recorded at 1.3 degrees C for 6hrs 5 min. Vaccine was administered to individual on 20Jul2010. Clinic reports no adverse event noted.
Hot flashes; mild fever (99.7); sore arm; swollen lymph nodes; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0167) via an unspecified route of administration in the arm left on 02May2021 at 12:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included "birth control"(unspecified medication). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0151) via an unspecified route of administration in the arm left on 04Apr2021 at 11:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 02May2021 at 13:00, the patient experienced hot flashes, mild fever(99.7), sore arm and swollen lymph nodes. The patient underwent lab test which included body temperature on 02May2021 and resulted with a temperature of 99.7(unspecified units). The clinical outcome of the events hot flashes, fever, sore arm and swollen lymph nodes were not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.